BPB Reports
暂无分享,去创建一个
N. Fujita | Y. Eto | Y. Eto | Norihisa Fujita
[1] F. Portillo,et al. UPR: An Upstream Signal to EMT Induction in Cancer , 2019, Journal of clinical medicine.
[2] B. Ahmmed,et al. Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-κB signaling pathway , 2018, International journal of oncology.
[3] Xiaoli Wang,et al. Tunicamycin suppresses breast cancer cell growth and metastasis via regulation of the protein kinase B/nuclear factor-κB signaling pathway , 2018, Oncology Letters.
[4] SHUPING YOU,et al. Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway , 2018, Molecular medicine reports.
[5] Shengshi Huang,et al. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer , 2017, Cancer Chemotherapy and Pharmacology.
[6] J. Diehl,et al. The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. , 2016, Current molecular medicine.
[7] Min Lu,et al. Activation of IRE1α-XBP1 pathway induces cell proliferation and invasion in colorectal carcinoma. , 2016, Biochemical and biophysical research communications.
[8] E. Oh,et al. Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells , 2015, Laboratory Investigation.
[9] J. K. Leach,et al. Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering. , 2015, Tissue engineering. Part B, Reviews.
[10] Feng-Chiao Tsai,et al. Ca2+ Signaling in Cytoskeletal Reorganization, Cell Migration, and Cancer Metastasis , 2015, BioMed research international.
[11] Y. Yung,et al. LPA receptor signaling: pharmacology, physiology, and pathophysiology , 2014, Journal of Lipid Research.
[12] N. Fujita,et al. GPR87 mediates lysophosphatidic acid-induced colony dispersal in A431 cells. , 2013, European journal of pharmacology.
[13] Masaya Imoto,et al. Comparative Analysis of the Expression Patterns of UPR-Target Genes Caused by UPR-Inducing Compounds , 2013, Bioscience, biotechnology, and biochemistry.
[14] D. Pincus,et al. Endoplasmic reticulum stress sensing in the unfolded protein response. , 2013, Cold Spring Harbor perspectives in biology.
[15] P. Walter,et al. The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation , 2011, Science.
[16] D. Ann,et al. Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein. , 2011, American journal of respiratory cell and molecular biology.
[17] T. Blackwell,et al. Alveolar Epithelial Cells Undergo Epithelial-to-Mesenchymal Transition in Response to Endoplasmic Reticulum Stress* , 2011, The Journal of Biological Chemistry.
[18] G. Tigyi. Aiming drug discovery at lysophosphatidic acid targets , 2010, British journal of pharmacology.
[19] V. Quaranta,et al. Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal , 2010, Journal of oncology.
[20] Kyoko Noguchi,et al. LPA receptors: subtypes and biological actions. , 2010, Annual review of pharmacology and toxicology.
[21] Gerhard Christofori,et al. EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.
[22] W. Sommergruber,et al. hGPR87 contributes to viability of human tumor cells , 2008, International journal of cancer.
[23] A. Shiraishi,et al. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. , 2007, Biochemical and biophysical research communications.
[24] T. Fujita,et al. Lysophosphatidic acid induces ME180 cell migration via its putative receptor GPR87 , 2015 .
[25] M. Lazzara,et al. ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. , 2014, Cancer research.